University of Alabama Hospital (Montgomery) Psychiatry

Topics

• Amyotrophic Lateral Sclerosis Research 38
• Alzheimer's disease research and treatments 31
• Dementia and Cognitive Impairment Research 20
• Neuroscience and Neuropharmacology Research 8
• Parkinson's Disease Mechanisms and Treatments 5
• Epilepsy research and treatment 4
• Neuroinflammation and Neurodegeneration Mechanisms 4
• Ethics in Clinical Research 3
• Genetic Neurodegenerative Diseases 3
• Prion Diseases and Protein Misfolding 3
• Bioinformatics and Genomic Networks 2
• Genomics and Rare Diseases 2

Most cited

1. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

   Nature medicine · 2021 · 305 citations · Erika Roberson

2. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.

   The Lancet. Neurology · 2025 · 51 citations · Erika Roberson

3. Temporal order of clinical and biomarker changes in familial frontotemporal dementia.

   Nature medicine · 2022 · 125 citations · Erika Roberson

4. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.

   Neurology · 2021 · 90 citations · Erika Roberson

5. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.

   Genome biology · 2025 · 21 citations · Erika Roberson

6. Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

   Nature aging · 2025 · 20 citations · Erika Roberson